DESJARDINS, Clarissa,GROGAN, Donna Roy,PACKMAN, Jeffrey Neal,HARNETT, Mark
申请号：
PH12018502563
公开号：
PH12018502563A1
申请日:
2018.12.05
申请国别(地区):
PH
年份:
2019
代理人:
摘要：
The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare- ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
